44P Value of comprehensive genomic profiling in pre-screening patients for NTRK fusion in STARTRK2 trial: Single centre experience

Abstract

Conclusions:The results of the study showed that oral administration of quercetin can inhibit the ability of tumour cells to proliferate suggesting the possibility to use as it chemopreventive agent in oncology.Legal entity responsible for the study: The authors.